SMART coils for intracranial aneurysm embolization: Follow-up outcomes.


Journal

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
ISSN: 1532-2653
Titre abrégé: J Clin Neurosci
Pays: Scotland
ID NLM: 9433352

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 13 06 2018
accepted: 27 10 2018
pubmed: 12 11 2018
medline: 14 2 2019
entrez: 12 11 2018
Statut: ppublish

Résumé

The SMART coil (Penumbra Inc., Alameda, CA, USA) is a new microcoil designed to enhance deliverability. Although prior studies have described its perioperative safety and efficacy, the follow-up outcomes after embolization of intracranial aneurysms using SMART coils have not been reported. Therefore, the aim of this retrospective cohort study is to assess the angiographic outcomes at interim follow-up after aneurysm embolization with SMART coils. We reviewed data from consecutive patients with intracranial aneurysms who underwent endovascular treatment using SMART coils between June 2016 and August 2017. Baseline data and follow-up angiographic outcomes using the modified Raymond-Roy classification (MRRC) were recorded. The study cohort comprised 33 patients with 34 aneurysms who underwent SMART coil embolization and had sufficient follow-up data. The mean age was 57 years, and 82% were female. The mean aneurysm maximum diameter and neck width were 6.1 ± 2.2 mm and 3.2 ± 1.2 mm, respectively, and 14.7% of aneurysms were ruptured. The overall complication rate was 12%. Initial mean coil packing density was 26%, and the initial MRRC was I, II, IIIa, and IIIb in 24%, 26%, 35%, and 15%, respectively. At last follow-up (mean duration 7.7 ± 3.2 months), the MRRC was I, II, IIIa, and IIIb in 62%, 26%, 3%, and 9%, respectively. The retreatment rate was 14.7%. The SMART coil is efficacious for the treatment of appropriately selected aneurysms, with an acceptable risk profile. The majority of residual aneurysms after the initial embolization procedure will progress to complete or near-complete occlusion at interim follow-up.

Identifiants

pubmed: 30414808
pii: S0967-5868(18)31040-3
doi: 10.1016/j.jocn.2018.10.132
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

93-97

Informations de copyright

Copyright © 2018. Published by Elsevier Ltd.

Auteurs

Jennifer D Sokolowski (JD)

Department of Neurological Surgery, University of Virginia, Charlottesville, VA, United States. Electronic address: soko@virginia.edu.

Adeel Ilyas (A)

Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL, United States.

Thomas J Buell (TJ)

Department of Neurological Surgery, University of Virginia, Charlottesville, VA, United States.

Davis G Taylor (DG)

Department of Neurological Surgery, University of Virginia, Charlottesville, VA, United States.

Ching-Jen Chen (CJ)

Department of Neurological Surgery, University of Virginia, Charlottesville, VA, United States.

Dale Ding (D)

Department of Neurosurgery, University of Louisville, Louisville, KY, United States.

Daniel M S Raper (DMS)

Department of Neurological Surgery, University of Virginia, Charlottesville, VA, United States.

Kenneth C Liu (KC)

Department of Neurological Surgery, Pennsylvania State University, Hershey, PA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH